U.S. Cannabis Testing Market 2021 Regional Growth Drivers, Opportunities, Trends, and Forecasts to 2027

U.S. Cannabis Testing Market 2021 Regional Growth Drivers, Opportunities, Trends, and Forecasts to 2027

U.S. Cannabis Testing Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

As the legalization of medicinal usage of cannabis in the U.S. is increasing in line with the stringent regulatory scenario in the country to ensure that high-quality cannabis is being delivered to the consumers for recreational and treatment of several  medical conditions, U.S. cannabis testing market is estimated to foresee a tremendous growth over the upcoming years. Further, FDA has made several resources available for addressing cannabis such as CBD to ensure that consumers and stakeholders can avail these resources in a centralized location. To illustrate, FDA is committed to work with the regulatory officials of State, Local, Tribal, Territorial (SLTT) for testing and commercialization of cannabis for medical and adult-use across various states of the U.S.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/4481

According to GMI, U.S. Cannabis testing market size is projected to surpass USD 4.1 billion at a CAGR of 10.4% through 2027, in light of below mentioned trends:

Strategic initiatives by major industry players

Prominent players operating in the U.S. cannabis testing market such as CannaSafe, Anresco, Collective Wellness of California, EVIO, Inc., Digipath, Inc, PSI Labs, SC Labs, Inc., Steep Hill, Inc. etc. are focusing on developing enhanced cannabis testing solutions and accreditation for gaining strong market presence worldwide. For instance, in 2018, CannaSafe announced that it received accreditation for laboratory analysis of medical cannabis products as a part of the Americans for Safe Access Patient Focused Certification program. This is a third-party certification program designed specifically for medical cannabis industry.

Citing another instance, in 2019, a leading cannabis resource Leafly, introduced the Leafly Certified Labs Program, under which a network of labs is independently assessed by Leafly for quality and accuracy. This program has been designed to address inconsistency in cannabis testing by ensuring that the lab data pertaining with cannabis comes from labs that have been confirmed to provide accurate results.

Rising adoption of liquid chromatography technique

As majority of cannabis testing procedures are carried out using liquid chromatography, it is estimated to witness higher preference over the coming years. In 2020, liquid chromatography segment recorded a valuation of USD 662.4 million. Further, liquid chromatography is a valuable alternative to gas chromatography when it comes to analysis of cannabinoids, pesticides and THC which is why this technology is often preferred for potency testing as it offers more precise analysis. Moreover, purification standards are highly controlled in liquid chromatography which helps in obtaining accurate results, which is complementing the segment growth.

Growing popularity of heavy metals testing for cannabis

Heavy metals are known to be one of the major contaminants found in cannabis and its products apart from residual solvents, microbial organisms and pesticides. In addition, heavy metals are highly toxic in nature and on exposure can lead to poisoning and other complications. As a result, heavy metal testing for cannabis and its products is increasingly becoming popular. Several government organizations have made heavy metal testing mandatory for cannabis products. Moreover, increasing legalization of cannabis across several countries for recreational and medicinal purposes is likely to instigate the demand for heavy metal testing of cannabis products, thereby fostering the growth of heavy metals testing segment over the coming years. For the records, in 2020, the segment had recorded a market revenue of USD 352.5 million.

Increasing support from government bodies in Mountain States zone of the U.S.

With increasing legalization of the usage of cannabis for medical and adult-use, cannabis testing market in Mountain States zone of the U.S. is likely to observe a tremendous growth over time. Moreover, growing support from various government bodies is playing a key role in enhancing the business space. For instance, ANSI National Accreditation Board offers accreditation to several independent and third-party laboratories that are involved in providing cannabis testing services. Further, presence of large number of cultivators of cannabis and manufacturers of cannabis-based products is also positively influencing the regional market growth. Considering the significance of these growth rendering factors, U.S. cannabis testing market from Mountain States zone is estimated to register a substantial CAGR of 9.6% through 2027. 

Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/us-cannabis-testing-market

Partial Chapter of the Table of Content 

Chapter 2   Executive Summary

2.1    U.S. cannabis testing industry 360° synopsis, 2016 - 2027

2.1.1    Business trends

2.1.2    Technology trends

2.1.3    Test type trends

2.1.4    Zone trends

2.1.5    state trends

Chapter 3   US Cannabis Testing Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 - 2027

3.3    Industry impact forces

3.3.1    Growth drivers    Growing legalization pertaining to the use of cannabis across various U states    Rigorous regulatory requirements implemented by authorities to ensure superior quality products    Rise in the number of testing laboratories and increasing cultivators of marijuana

3.3.2    Industry pitfalls & challenges    Lack of uniform testing standards    High cost of setting up a cannabis testing facility

3.4    Growth potential analysis

3.4.1    By technology

3.4.2    By test type

3.5    COVID-19 impact analysis

3.6    Regulatory scenario

3.6.1    Alaska

3.6.2    Arizona

3.6.3    Arkansas

3.6.4    California

3.6.5    Colorado

3.6.6    Connecticut

3.6.7    Delaware

3.6.8    Florida

3.6.9    Hawaii

3.6.10    Illinois

3.6.11    Louisiana

3.6.12    Maine

3.6.13    Maryland

3.6.14    Massachusetts

3.6.15    Michigan

3.6.16    Minnesota

3.6.17    Montana

3.6.18    Nevada

3.6.19    New Hampshire

3.6.20    New Jersey

3.6.21    New Mexico

3.6.22    New York

3.6.23    Pennsylvania

3.6.24    Ohio

3.6.25    Oklahoma

3.6.26    Oregon

3.6.27    Rhode Island

3.6.28    Utah

3.6.29    Vermont

3.6.30    Washington

3.6.31    Washington D.C.

3.7    Pricing analysis

3.8    Porter’s analysis

3.9    Competitive landscape, 2019

3.9.1    Competitive dashboard

3.10    PESTEL analysis